Sphingosine kinase activation mediates ischemic preconditioning in murine heart

Circulation

Volumn 110, Issue 14, 2004, Pages 1980-1989

  Jin, Zhu Qiu ^a   Goetzl, Edward J ^a   Karliner, Joel S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cardiology Section (111C)   (United States)

Author keywords

Enzymes; Ischemia; Myocardial infarction; Signal transduction

Indexed keywords

ENZYME INHIBITOR; GANGLIOSIDE GM1; N,N DIMETHYLSPHINGOSINE; PROTEIN KINASE C EPSILON; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; ISOLATED HEART; MOUSE; NONHUMAN; PHOSPHORYLATION AND DEPHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANIMALS; CARDIOTONIC AGENTS; ENZYME ACTIVATION; G(M1) GANGLIOSIDE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 4944246652     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000143632.06471.93     Document Type: Article

References (44)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
2. Yellon DM, Dana A. The preconditioning phenomenon: a tool for the scientist or a clinical reality. Circ Res. 2000;87:543-550.
3. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res. 2001;52:181-198.
4. Spiegel S, Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem. 2002;277:25851-25854.
5. Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ. Lysophospholipids-receptor revelations. Science. 2001;294:1875-1878.
6. Payne SG, Milstien S, Spiegel S. Sphingosine-1-phosphate: dual messenger functions. FEBS Lett. 2002;531:54-57.
7. Karliner JS. Lysophospholipids and the cardiovascular system. Biochim Biophys Acta. 2002;1582:216-221.
8. Karliner JS, Honbo N, Summers K, Gray MO, Goetzl EJ. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol. 2002;33:1713-1717.
9. Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, Messing RO, Goetzl EJ, Karliner JS, Gray MO. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse heart. Am J Phyisol Heart Circ Physiol. 2002;282:H1970-H1977.
10. Kohama T, Olivera A, Edsall L, Nagiec MM, Dickson R, Spiegel S. Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem. 1998;273:23722-23728.
11. Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S, Milstien S, Kohama T, Spiegel S. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem. 2002;275:19513-19520.
12. Fukuda Y, Kihara A, Igarashi Y. Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. Biochem Biophys Res Commun. 2003;309:155-160.
13. Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S, Spiegel S. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol. 1999;147:545-558.
14. Johnson KR, Becker KP, Facchinetti MM, Hannun YA, Obeid LM. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. J Biol Chem. 2002;277:35257-35262.
15. Gray MO, Zhou HZ, Schafhalter-Zoppoth I, Zhu P, Mochly-Rosen D, Messing RO. Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C epsilon. J Biol Chem. 2004;279:3596-3604.
16. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res. 1997;81:404-414.
17. Edmondson RD, Vondriska TM, Biederman KJ, Zhang J, Jones RC, Zheng Y, Allen DL, Xiu JX, Cardwell EM, Pisano MR, Ping P. Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complementary separation techniques with LC/MS/MS. Mol Cell Proteomics. 2002;1:421-433.
18. Olivera A, Barlow KD, Spiegel S. Assaying sphingosine kinase activity. Methods Enzymol. 1999;311:215-223.
19. Khan WA, Dobrowsky R, el Touny S, Hannun YA. Protein kinase C and platelet inhibition by D-erythro-sphingosine: comparison with N,N-dimethylsphingosine and commercial preparation. Biochem Biophys Res Commun. 1990;172:683-691.
20. Igarashi Y, Hakomori S, Toyokuni T, Dean B, Fujita S, Sugimoto M, Ogawa T, el-Ghendy K, Racker E. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry. 1989;28:6796-6800.
21. Edsall LC, Van Brocklyn JR, Cuvillier O, Kleuser B, Spiegel S. N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry. 1998;37:12892-12898.
22. Albert CJ, Ford DA. Protein kinase C translocation and PKC-dependent protein phosphorylation during myocardial ischemia. Am J Physiol Heart Circ Physiol. 1999;276:H642-H650.
23. Simonis G, Weinbrenner C, Strasser RH. Ischemic preconditioning promotes a transient, but not sustained translocation of protein kinase C and sensitization of adenylyl cyclase. Basic Res Cardiol. 2003;98:104-113.
24. Tekin D, Xi L, Zhao T, Isabel Tejero-Taldo M, Atluri S, Kukreja RC. Mitogen-activated protein kinases mediate heat shock-induced delayed protection in mouse heart. Am J Physiol Heart Circ Physiol. 2001;281:H523-H532.
25. Cavallini L, Vernerando R, Miotto G, Alexander A. Ganglioside GM-1 protection from apoptosis of rat heart fibroblasts. Arch Biochem Biophys. 1999;370:156-162.
26. 2+ signaling by G-protein-coupled receptors. EMBO J. 1998;17:2830-2837.
27. van Koppen CJ, Meyer zu Heringdorf D, Lass H, Alemany R, Jakobs KH. Sphingosine kinase-mediated calcium signaling by muscarinic acetylcholine receptors. Life Sci. 2001;68:2535-2540.
28. 2 receptor and its implication in regulation of the ERK/MAP kinase pathway. Biol Chem. 2001;382:135-139.
29. 2+ mobilization requires intracellular sphingosine 1-phosphate production: potential involvement of endogenous EDG-4 receptors. J Biol Chem. 2000;275:38532-38539.
30. Meyer zu Heringdorf D, Lass H, Kuchar I, Lipinski M, Alemany R, Rumenapp U, Jakobs KH. Stimulation of intracellular sphingosine-1-phosphate phosphate production by G-protein-coupled sphingosine-1-phosphate receptors. Eur J Pharmacol. 2001;414:145-154.
31. Mazurek N, Megidish T, Hakomori S, Iarashi Y. Regulatory effect of phorbol esters on sphingosine kinase in BALA/C 3T3 fibroblasts (variant A31): demonstration of cell type-specific response-a preliminary note. Biochem Biophys Res Commun. 1994;198:1-9.
32. Buehrer BM, Bardes ES, Bell RM. Protein kinase C-dependent regulation of human erythroleukemia (HEL) cell sphingosine kinase activity. Biochim Biophys Acta. 1996;1303:233-242.
33. Kaneider NC, Djanani A, Fischer-Colbrie R, Wiedermann CJ. Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester. Biochem Biophys Res Commun. 2002;297:806-810.
34. Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN. Identification of a novel role for sphingolipid signaling in TNF-α and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol. 2002;34:509-518.
35. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res. 2001;52:181-198.
36. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C. Am J Physiol. 1994;266:H1145-H1152.
37. Saurin AT, Pennington DJ, Raat NJH, Latchman DS, Owen MJ, Marber MS. Targeted disruption of the protein kinase Cε gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res. 2002;55:672-680.
38. Gray MO, Karliner JS, Mochly-Rosen D. A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem. 1997;272:30945-30951.
39. Wang F, Buckley NE, Olivera A, Goodemote KA, Su Y, Spiegel S. Involvement of sphingolipids metabolites in cellular proliferation modulated by ganglioside GM1. Glycoconj J. 1996;13:937-945.
40. Yatomi Y, Ruan F, Megidish T, Toyokuni T, Hakomori S, Igarashi Y. N,N-Dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry. 1996;35:626-633.
41. ATP channel occurs downstream of PKC-ε activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol. 2002;283:H440-H447.
42. Kluk MJ, Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim Biophys Acta. 2002;1582:72-80.
43. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signaling lipid. Nat Rev Mol Cell Biol. 2003;4:397-407.
44. Cui J, Engelman RM, Maulik N, Das DK. Role of ceramide in ischemic preconditioning. J Am Coll Surg. 2004;198:770-777.